A5032347926- Substance Abuse Treatment and Outcomes
- Opioid Use Disorder Treatment
- Prenatal Substance Exposure Effects
- Cannabis and Cannabinoid Research
- Mental Health Treatment and Access
- Homelessness and Social Issues
- Alcohol Consumption and Health Effects
- Smoking Behavior and Cessation
- Child and Adolescent Psychosocial and Emotional Development
- Schizophrenia research and treatment
- Pain Management and Opioid Use
- Forensic Toxicology and Drug Analysis
- Treatment of Major Depression
- Neurotransmitter Receptor Influence on Behavior
- HIV, Drug Use, Sexual Risk
- Suicide and Self-Harm Studies
- Health disparities and outcomes
- Health Policy Implementation Science
- Pharmaceutical Practices and Patient Outcomes
- Alcoholism and Thiamine Deficiency
- Obesity, Physical Activity, Diet
- Blood Pressure and Hypertension Studies
- Mental Health Research Topics
- Emergency and Acute Care Studies
- Carcinogens and Genotoxicity Assessment
University of Toronto
2025
Hospital for Sick Children
2025
SickKids Foundation
2025
Duke University
2015-2024
Center for Child and Family Health
2015-2024
Shanghai University of Medicine and Health Sciences
2024
Duke University Hospital
2013-2022
Duke Medical Center
2013-2022
Clinical Research Institute
2008-2021
Anhui University
2021
The United States is experiencing an opioid overdose epidemic. Treatment use data from diverse racial/ethnic groups with disorder (OUD) are needed to inform treatment expansion efforts.We examined demographic characteristics and behavioral health of persons aged ≥12 years that met criteria for past-year OUD (n=6,125) in the 2005-2013 National Surveys on Drug Use Health (N=503,101). We determined prevalence correlates alcohol/drug opioid-specific efforts improving treatment.Among OUD, 81.93%...
Objective: The purpose of this article was to estimate the prevalence, distribution, and correlates at-risk alcohol use (especially binge drinking) among middle-aged elderly persons in United States compare between women men. Method: Secondary analysis 2005 2006 National Survey on Drug Use Health conducted for 10,953 respondents aged 50 years older. Among respondents, 6,717 were 64 age 4,236 ≥65 years. Social demographic variables, (including use), drinking, serious psychological distress,...
Background: Substance use, a leading cause of illness and death, is underidentified in medical practice. Objective: The Tobacco, Alcohol, Prescription medication, other use (TAPS) tool was developed to address the need for brief screening assessment instrument that includes all commonly used substances fits into clinical workflows. goal this study assess performance TAPS primary care patients. Design: Multisite study, conducted within National Drug Abuse Treatment Clinical Trials Network,...
Background: Drug use–associated infective endocarditis (DUA-IE) is increasing as a result of the opioid epidemic. Infective may require valve surgery, but surgical treatment DUA-IE has invoked controversy, and extent its use unknown. Objective: To examine hospitalization trends for DUA-IE, proportion hospitalizations with patient characteristics, length stay, charges. Design: 10-year analysis statewide hospital discharge database. Setting: North Carolina hospitals, 2007 to 2017. Patients:...
OBJECTIVES: This study builds on previous observations about a suspected causal association linking tobacco smoking with depression. With prospective data, the sheds new light temporal sequencing of and depressed mood in late childhood early adolescence. METHODS: The epidemiologic sample that was studied consisted 1731 youths (aged 8-9 to 13-14 years) attending public schools mid-Atlantic metropolitan area, who were assessed at least twice from 1989 1994. A survival analysis used examine...
<h3>Context</h3>While young racial/ethnic groups are the fastest growing population in United States, data about substance-related disorders among adolescents of various backgrounds lacking.<h3>Objective</h3>To examine magnitude past-year DSM-IV (alcohol, marijuana, cocaine, inhalants, hallucinogens, heroin, analgesic opioids, stimulants, sedatives, and tranquilizers) white, Hispanic, African American, Native Asian or Pacific Islander, multiple race/ethnicity.<h3>Design</h3>The 2005 to 2008...
Minority groups generally experience more disparities than whites in behavioral healthcare use. The population of racial/ethnic is growing faster whites. Given increased concerns cannabis use (CU) and its associations with health conditions, we examined national trends disorder (CUD) among adults aged ≥18 by race/ethnicity.Data were from the 2005-2013 National Surveys on Drug Use Health (N=340,456). We compared CU patterns conditional prevalence CUD users race/ethnicity to understand...
Chronic diseases are prevalent and the leading causes of mortality. Comorbidity substance use disorders (SUDs) chronic is understudied to inform behavioral healthcare integration. This study leveraged electronic health record (EHR) data 211,880 adults from a large system examine prevalence correlates comorbidity SUDs nine disease groups determine their association with hospitalization. Logistic regression analyses were conducted estimate associations between SUDs. To control for severity...
The increase in cannabis potency may have treatment implications for use disorder (CUD). Given the reported prevalence of among adults, there is a need to understand substance needs CUD. We examined demographics and behavioral health indicators adults aged ≥18 years that met criteria past-year CUD (n = 10,943) 2005–2013 National Surveys on Drug Use Health. determined correlates alcohol/drug, any drug, related problems, inform efforts majority with were young 18–25 or men, had low income, did...
Methylphenidate, atomoxetine, and amphetamine are the most commonly prescribed medications for ADHD, approved by FDA. Despite their widespread use, real-world studies on serious adverse effects limited. This study leverages FAERS database to analyze safety of these drugs. A retrospective analysis was conducted using data from 2004 2023. Adverse event (AE) signals methylphenidate, were identified calculating reporting odds ratios (RORs), proportional (PRRs), information components (ICs),...
OBJECTIVE: This study sought to determine how comorbidity of psychiatric and substance abuse disorders affects the likelihood using mental health services. METHOD: The analysis was based on data adults aged 18–54 years in National Comorbidity Survey (N=5,393). Users nonusers services were compared terms their demographic characteristics, recent stressful life events, social support, parental history psychopathology, self-medication, symptoms alcohol abuse/dependence. RESULTS: prevalence...